15th ANNUAL EARLY HEARING DETECTION & INTERVENTION MEETING
March 13-15, 2016 • San Diego, CA
3/14/2016 | 2:00 PM - 2:30 PM | Topical Session 2 | Pacific Salon 1 | 2 - Audiological Services
Risk Monitoring for Delayed-Onset Hearing Loss
Joint Committee on Infant Hearing (JCIH) recommends audiological monitoring for newborns identified with risk indicators for delayed-onset hearing loss. The list of risk indicators includes caregiver concerns, family history of permanent childhood hearing loss, NICU stay greater than 5 days, assisted ventilation, ototoxic medications, hyperbilirubinemia requiring transfusions, in-utero infections, craniofacial anomalies, physical findings or syndromes associated with hearing loss or progressive or late-onset hearing loss, neurodegenerative disorders, culture-positive postnatal infections associated with hearing loss, head trauma and chemotherapy. Some risk indicators are more concerning and require frequent audiological monitoring. JCIH 2007 position statement did not provide a detailed protocol for monitoring of risk indicators in infants. As a result, there are inconsistencies in risk monitoring protocols from state to state, clinic to clinic, and even audiologist to audiologist.
This presentation provides current information regarding Idaho’s “best practice” protocol for monitoring risk indicators in newborns and young children. The pros and cons of the current risk monitoring protocol will be addressed. The presentation will provide a look into a risk monitoring protocol currently in Idaho. In Idaho, approximately 50% of infants identified with hearing loss present with risk indicators. At least half of infants with risk indicators and diagnosed hearing loss had more than one risk indicator identified. Data will be presented on the incidence and prevalence of risk indicators and diagnosed hearing loss in Idaho. The presentation addresses risk monitoring tracking procedures at the clinic level and across Idaho.
Overall, the presentation describes risk indicators for late onset hearing loss, provides audiology protocols for risk monitoring and provides guidance for tracking risk indicators at a clinic and state level.
- Learner will be able to identify risk indicators which require monitoring for delayed-onset hearing loss.
- Learner will be able to identify risk indicators which require more frequent audiological monitoring.
- Learner will be able to explain options for risk monitoring protocols.
Presentation:
This presentation has not yet been uploaded or the speaker has opted not to make the presentation available online.
Handouts:
Handout is not Available
CART:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
(), ;
ASHA DISCLOSURE:
Financial -
Nonfinancial -
Jessica Stich-Hennen
(Primary Presenter), Idaho Elks Hearing & Balance Center -Boise , stichhej@slhs.org;
Dr. Jessica Stich-Hennen received her Clinical Doctorate in Audiology (Au.D.) from the Idaho State University. In April 2011, she achieved Specialty Certification in Pediatrics from American Board of Audiology. Dr. Stich-Hennen’s clinical specialty areas include pediatrics diagnostics and amplification, auditory evoked potentials and auditory processing disorders. She is the primary audiologist for the Idaho Cleft Palate-Craniofacial team.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exist.
Nonfinancial -
No relevant nonfinancial relationship exist.
Gabriel Bargen
(Author), Idaho State University, barggabr@isu.edu;
Dr. Bargen is an Assistant Professor at Idaho State University in the Department of
Communication Sciences and Disorders at the Meridian Health Science Center. She
earned an MA and PhD in audiology from University of Kansas and an MSEd in speechlanguage
pathology from University of Nebraska at Kearney. She teaches courses at ISU,
including pediatric audiology, hearing conservation, advance aural rehabilitation, and
auditory language learning. Professional interests include pediatric audiology specifically
disorders, hearing assessment and treatment; assessing risks associated with hearing
dysfunction in infants; clinical application of auditory brainstem response (ABR) for
hearing loss screening in newborns, infants, and toddlers. Dr. Bargen’s current research
focuses on comparing chirp and click stimuli ABR measurements in the pediatric
population.
ASHA DISCLOSURE:
Financial -
Nonfinancial -